Home > News > Nanogen Issued Patent for Addressable Biologic Electrode Arrays
January 28th, 2004
Nanogen Issued Patent for Addressable Biologic Electrode Arrays
Abstract:
Nanogen, Inc. announced today that it was issued U.S. Patent No. 6,682,936, "Addressable Biologic Electrode Array," by the U.S. Patent and Trademark Office. The '936 patent relates to electrode-based array devices and methods of operation in which individual electrodes contained within the array can be selectively addressed or manipulated. The technology enables high-density electrode arrays to be produced and has applications for the hybridization as well as combinatorial synthesis and self-assembly of biological molecules, such as nucleic acids and peptides.
Source:
Nanogen
Bookmark:
| Related News Press |
Announcements
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||